Comparative proteomic analysis of Staphylococcus aureus strains with differences in resistance to the cell wall-targeting antibiotic vancomycin.
about
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsQuantitative proteomic view associated with resistance to clinically important antibiotics in Gram-positive bacteria: a systematic reviewCharacterizing the Escherichia coli O157:H7 proteome including protein associations with higher order assembliesWidespread Occurrence of Non-Enzymatic Deamidations of Asparagine Residues in Yersinia pestis Proteins Resulting from Alkaline pH Membrane Extraction Conditions.Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains.Physiological significance of the peptidoglycan hydrolase, LytM, in Staphylococcus aureusAnti-staphylococcal activities of lysostaphin and LytM catalytic domainProteomic View of Interactions of Shiga Toxin-Producing Escherichia coli with the Intestinal Environment in Gnotobiotic Piglets.Dormant cells of Staphylococcus aureus are resuscitated by spent culture supernatant.Proteomics as the final step in the functional metagenomics study of antimicrobial resistance.Rapid Detection of Vancomycin-Intermediate Staphylococcus aureus by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.High resolution structure of an M23 peptidase with a substrate analogue.Comparative proteomics-based identification of genes associated with glycopeptide resistance in clinically derived heterogeneous vancomycin-intermediate Staphylococcus aureus strains.Decreased vancomycin susceptibility in Staphylococcus aureus caused by IS256 tempering of WalKR expression.Comparison of two label-free global quantitation methods, APEX and 2D gel electrophoresis, applied to the Shigella dysenteriae proteome.sarA inactivation reduces vancomycin-intermediate and ciprofloxacin resistance expression by Staphylococcus aureus.Analysis of the proteome of intracellular Shigella flexneri reveals pathways important for intracellular growth.Investigating pathogen biology at the level of the proteome.Pan-proteomics, a concept for unifying quantitative proteome measurements when comparing closely-related bacterial strains.Mass spectrometry methods for predicting antibiotic resistance.Activated ADI pathway: the initiator of intermediate vancomycin resistance in Staphylococcus aureus.Simultaneous Identification of Multiple β-Lactamases in Acinetobacter baumannii in Relation to Carbapenem and Ceftazidime Resistance, Using Liquid Chromatography-Tandem Mass Spectrometry.A mutation of RNA polymerase β' subunit (RpoC) converts heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) into "slow VISA"Characterization of IsaA and SceD, two putative lytic transglycosylases of Staphylococcus aureus.Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenemInteraction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.Small colony variants of Staphylococcus aureus reveal distinct protein profiles.
P2860
Q24646677-94F3EDEA-1209-4DC5-9D95-B05E71E37A51Q26796165-86F4F5F5-B65B-44CB-9397-D90DD1B730EDQ28477828-D53C13FB-661C-48BD-B7D2-32E5EB308166Q33813110-6A93AAD6-DA08-47E0-A03E-81717E970B57Q34130471-F8DF9BA5-E50D-41C3-B415-B54A2B3AAE46Q34152544-DFA61FED-E3BE-47C3-B543-2326524707E7Q34294373-07C91AD7-FC21-4CEA-A6AE-A5E1A8261708Q34805497-70C49D07-A863-4A46-B6DE-527D4EEC6894Q35093506-FFD68C57-D8F7-4BC9-ABB6-2D891F94AF1AQ35140858-D4D47DBF-4964-4BF6-B773-9B0EAC8192F4Q35893439-9BA9E29A-855C-43F2-B1DE-2CE4762D9758Q36123695-C9C6AEC7-58C8-4390-AA78-CA955901CDBAQ36964857-E2006C40-966E-4D2C-BFC3-72E2DCD5CB6AQ36969754-2E39FB74-E1ED-45ED-92E7-EACCBABD6328Q37276634-BDD11DB7-2B5F-4670-BB6C-EB6C9963ED1AQ37318624-2587EE3F-9916-451A-9678-2C62F4FE1438Q37336082-E2404B87-BA75-409F-ADA8-49D3570549AFQ37897209-AED1DB84-FB2A-42A1-80EE-69698652C1DBQ38738567-577AFAC9-226D-4CE0-8AA0-CD043CB4CBE8Q38867552-37825BC9-34EF-4014-8A05-C0B6454BE411Q40383094-8599C380-DE3C-4E66-9913-D054ACAE814AQ40673302-F3DB39E7-C9B4-416A-A319-1E35465C41CEQ41259277-43CC48C8-7D37-42FD-8287-C6431B45A6F6Q42059030-B46AA304-93FC-4E45-8381-CD0B6F6E0769Q42111612-1941C2C1-390A-42D2-A75E-7EB9FE45C2EBQ42119436-44E56989-9D4A-44C2-A847-1A67596F9E1FQ54372273-50335D65-2035-4047-9F56-9456EE497655
P2860
Comparative proteomic analysis of Staphylococcus aureus strains with differences in resistance to the cell wall-targeting antibiotic vancomycin.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Comparative proteomic analysis ...... rgeting antibiotic vancomycin.
@ast
Comparative proteomic analysis ...... rgeting antibiotic vancomycin.
@en
type
label
Comparative proteomic analysis ...... rgeting antibiotic vancomycin.
@ast
Comparative proteomic analysis ...... rgeting antibiotic vancomycin.
@en
prefLabel
Comparative proteomic analysis ...... rgeting antibiotic vancomycin.
@ast
Comparative proteomic analysis ...... rgeting antibiotic vancomycin.
@en
P2093
P2860
P356
P1433
P1476
Comparative proteomic analysis ...... rgeting antibiotic vancomycin.
@en
P2093
Christine L Gatlin-Bunai
Emmanuel F Mongodin
Prashanth P Parmar
Rembert Pieper
Robert D Fleischmann
Scott N Peterson
Shih-Ting Huang
Steven R Gill
P2860
P304
P356
10.1002/PMIC.200500764
P577
2006-08-01T00:00:00Z